Eli Lilly Shares Rise After Drug Helps Patients Lose More Weight Than Competitors

Eli Lilly shares rose in early trading on Tuesday after a trial showed its retatrutide weight loss drug could help patients lose more weight than other drugs, including Novo Nordisk’s Ozempic.